FI964448A0 - Uusi biologisesti aktiivinen peptidi ja sen valmistus - Google Patents

Uusi biologisesti aktiivinen peptidi ja sen valmistus

Info

Publication number
FI964448A0
FI964448A0 FI964448A FI964448A FI964448A0 FI 964448 A0 FI964448 A0 FI 964448A0 FI 964448 A FI964448 A FI 964448A FI 964448 A FI964448 A FI 964448A FI 964448 A0 FI964448 A0 FI 964448A0
Authority
FI
Finland
Prior art keywords
pct
preparation
biologically active
active peptide
val
Prior art date
Application number
FI964448A
Other languages
English (en)
Swedish (sv)
Other versions
FI964448A (fi
FI119642B (fi
Inventor
Wilhelm Amberg
Harald Bernard
Ernst Buschmann
Andreas Haupt
Lothar Janitschke
Bernd Janssen
Ulrich Karl
Andreas Kling
Stefan Mueller
Potzolli Bernd De
Kurt Ritter
Marco Thyes
Thomas Zierke
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of FI964448A publication Critical patent/FI964448A/fi
Publication of FI964448A0 publication Critical patent/FI964448A0/fi
Application granted granted Critical
Publication of FI119642B publication Critical patent/FI119642B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI964448A 1994-05-06 1996-11-05 Antineoplastisen pentapeptidin kiteinen hydrokloridimuoto, sen valmistus ja välituotteet FI119642B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4415997 1994-05-06
DE4415997A DE4415997A1 (de) 1994-05-06 1994-05-06 Neuer peptidischer Wirkstoff und dessen Herstellung
EP9501577 1995-04-26
PCT/EP1995/001577 WO1995030691A1 (de) 1994-05-06 1995-04-26 Neuer peptidischer wirkstoff und dessen herstellung

Publications (3)

Publication Number Publication Date
FI964448A FI964448A (fi) 1996-11-05
FI964448A0 true FI964448A0 (fi) 1996-11-05
FI119642B FI119642B (fi) 2009-01-30

Family

ID=6517453

Family Applications (1)

Application Number Title Priority Date Filing Date
FI964448A FI119642B (fi) 1994-05-06 1996-11-05 Antineoplastisen pentapeptidin kiteinen hydrokloridimuoto, sen valmistus ja välituotteet

Country Status (28)

Country Link
US (1) US5864012A (fi)
EP (1) EP0758342B1 (fi)
JP (1) JPH09512803A (fi)
KR (1) KR100336139B1 (fi)
CN (1) CN1113067C (fi)
AT (1) ATE188485T1 (fi)
AU (1) AU688037B2 (fi)
BG (1) BG61610B2 (fi)
BR (1) BR9507623A (fi)
CZ (1) CZ288448B6 (fi)
DE (2) DE4415997A1 (fi)
DK (1) DK0758342T3 (fi)
ES (1) ES2141351T3 (fi)
FI (1) FI119642B (fi)
GR (1) GR3032630T3 (fi)
HR (1) HRP950271B1 (fi)
HU (1) HU220875B1 (fi)
IL (1) IL113544A (fi)
MX (1) MX9605402A (fi)
NO (1) NO317728B1 (fi)
NZ (1) NZ285092A (fi)
PL (1) PL180652B1 (fi)
PT (1) PT758342E (fi)
RU (1) RU2153504C2 (fi)
SI (1) SI9520061B (fi)
TW (1) TW408132B (fi)
WO (1) WO1995030691A1 (fi)
ZA (1) ZA953584B (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4415998A1 (de) * 1994-05-06 1995-11-09 Basf Ag Neue Tetrapeptide, ihre Herstellung Verwendung
US20010009901A1 (en) 1996-12-11 2001-07-26 Basf Aktiengesellschaft Germany Antineoplastic peptides
TW474946B (en) * 1995-12-15 2002-02-01 Basf Ag Novel compounds, the preparation and use thereof
US7304750B2 (en) * 1999-12-17 2007-12-04 Nektar Therapeutics Systems and methods for non-destructive mass sensing
KR20020066476A (ko) * 2001-02-12 2002-08-19 쥬가이 세이야쿠 가부시키가이샤 펩타이드 유도체의 제조방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT71398A (en) * 1992-05-20 1995-11-28 Basf Ag Derivatives of dolastatin

Also Published As

Publication number Publication date
CZ288448B6 (en) 2001-06-13
TW408132B (en) 2000-10-11
PL180652B1 (pl) 2001-03-30
PT758342E (pt) 2000-04-28
HU9603067D0 (en) 1997-01-28
NO964688D0 (no) 1996-11-05
HRP950271A2 (en) 1997-08-31
ATE188485T1 (de) 2000-01-15
EP0758342A1 (de) 1997-02-19
IL113544A (en) 2001-01-11
NO317728B1 (no) 2004-12-13
IL113544A0 (en) 1995-07-31
HU220875B1 (en) 2002-06-29
BR9507623A (pt) 1997-10-07
JPH09512803A (ja) 1997-12-22
ZA953584B (en) 1996-11-04
PL321159A1 (en) 1997-11-24
CN1162318A (zh) 1997-10-15
EP0758342B1 (de) 2000-01-05
AU2408395A (en) 1995-11-29
DE4415997A1 (de) 1995-11-09
GR3032630T3 (en) 2000-05-31
AU688037B2 (en) 1998-03-05
MX9605402A (es) 1997-12-31
KR100336139B1 (ko) 2002-09-25
ES2141351T3 (es) 2000-03-16
FI964448A (fi) 1996-11-05
US5864012A (en) 1999-01-26
SI9520061A (en) 1997-06-30
DE59507578D1 (de) 2000-02-10
WO1995030691A1 (de) 1995-11-16
KR970702880A (ko) 1997-06-10
CZ326096A3 (en) 1997-04-16
DK0758342T3 (da) 2000-05-01
NO964688L (no) 1997-01-02
FI119642B (fi) 2009-01-30
CN1113067C (zh) 2003-07-02
BG61610B2 (bg) 1998-01-30
HUT75861A (en) 1997-05-28
RU2153504C2 (ru) 2000-07-27
HRP950271B1 (en) 2000-08-31
NZ285092A (en) 1998-01-26
SI9520061B (sl) 2002-02-28

Similar Documents

Publication Publication Date Title
ES2082003T3 (es) Deshidrodidemnina b.
MX9709146A (es) Compuestos novedosos, preparacion y uso de los mismos.
TR200002248T2 (tr) Yeni dihidroksiheksanoik asit türevleri
DE69311541D1 (de) Kosmetische oder pharmazeutische zusammensetzungen zur topischen anwendung die deacylierten glycerophospholipide enthalten
DE69420145T2 (de) Behandlung präkanzeröser läsionen durch muramylpeptide
TR199900661T2 (xx) Cilt enfeksiyonlar�n�n tedavisi amac�yla 1-hidroksi-2-piridonlar�n kullan�m�
AU8332791A (en) Oral pharmaceutical compositions containing melatonin
SE9402880D0 (sv) New peptide derivatives
FI964448A (fi) Uusi biologisesti aktiivinen peptidi ja sen valmistus
AU1192397A (en) Substituted thiazolines and their use for controlling animal pests
ES2071343T3 (es) Nuevos peptidos con actividad anticoagulatoria.
ATE215361T1 (de) Liposomen mit mehrfach verzweigten peptidkonstruktionen zur verwendung gegen hiv
NZ324691A (en) Antineoplastic peptides
MX9307736A (es) Nuevas triazoloquinazolinas, su obtencion y uso.
AU5870298A (en) 1,4-dihydropyridin derivatives and their use in therapy
CA2189690A1 (en) Novel active peptide and its preparation
IT1216535B (it) O_(1,2_di_0_acetilglicero_3_fosforil)etanolamina, procedimento per la sua preparazione e suo uso terapeutico.

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: ABBVIE DEUTSCHLAND GMBH & CO KG

MA Patent expired